Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.870
-0.140 (-6.97%)
At close: May 16, 2025, 4:00 PM
1.832
-0.038 (-2.05%)
After-hours: May 16, 2025, 7:57 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $57.94 million as of May 16, 2025. Its market cap has decreased by -84.03% in one year.
Market Cap
57.94M
Enterprise Value
-871.09K
1-Year Change
-84.03%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $57.94M, a decrease of -83.73%. That is a compound annual growth rate of -81.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 62.30M | -27.47% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |